DOCSLIB.ORG

Expert Review of Proteomics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expert Review of Proteomics Expert Review of Proteomics Editorial Advisory Panel Overseeing the editorial content and development of Expert Review of Proteomics is an Editorial Advisory Board, composed of many of the world's leading experts in the field, drawn from both research and academia. Albala JS, UC Davis School of Medicine, CA, USA Apweiler R, European Bioinformatics Institute, Cambridge, UK Dr Rolf Apweiler studied Biology with an emphasis on Molecular Biology and Biochemistry at the University of Heidelberg, Germany and the University of Bath, UK. He worked between 1991-1994 in drug discovery at Boehringer Mannheim and has been involved in the Swiss-Prot project since 1987. He co- ordinates the Swiss-Prot knowledgebase group at the EBI since 1994, and started the TrEMBL, InterPro, Proteome analysis and CluSTr projects at the EBI. Since autumn 2001 he is also in charge of the EMBL nucleotide sequence database and started in 2002 the merge of the Swiss-Prot and TrEMBL projects with the PIR to UniProt. Dr Apweiler is heading a team of currently 100 biologists and programmers responsible for the UniProt, InterPro, Proteome analysis, CluSTr and EMBL nucleotide sequence database projects at the EBI. Rolf Apweiler's main research interests are focused on integrating heterogenous functional genomic and proteomic data resources with the main protein and nucleotide sequence databases, and automation of classification and annotation of protein sequences. Blackburn J, Cambridge University, Cambridge, UK Professor Blackburn received a doctorate and an honours degree in chemistry from the University of Oxford. Following his Doctorate, Professor Blackburn carried out post-doctoral research with Professor Fersht at the Centre for Protein Engineering in Cambridge. He then took up a Royal Society University Research Fellowship in the Biochemistry Department, University of Cambridge and was a Fellow of Fitzwilliam College, Cambridge. He has recently moved to take up a Chair in Biochemistry in the Department of Biotechnology, University of the Western Cape, Cape Town. His academic research has ranged from the synthesis of novel enzyme substrates and inhibitors, through molecular biology, protein chemistry and enzymology to the development of new display and array methodologies and the directed evolution of novel proteins. He has published extensively in highly qualified peer reviewed scientific journals and was a founder and the Chief Scientific Officer of Sense Proteomic Ltd. Following acquisition, he is now the Chief Scientist of Procognia Ltd. Borchers C, University of North Carolina, NC, USA Burchmore R, University of Glasgow, UK Dr Burchmore is Head of Proteomics at the Sir Henry Wellcome Functional Genomics Facility in the Institute of Biomedical and Life Sciences, University of Glasgow. He studied parasitology and biochemistry at the University of London, completing a PhD in 1993. This was followed by a postdoctoral fellowship at Oregon Health Sciences University, USA, and further postoctoral posts in the UK. Dr Burchmore has a long standing interest in the role of membrane proteins in cellular nutrient acquisition, and has published extensively in high quality journals. Current research interests focus on the application of proteomic technologies to membrane proteins, to elucidate the role of membrane transporters in pathogen virulence and drug resistance. Chen T, University of Southern California, CA, USA Dr Chen is an assistant professor of biological sciences, computer science and mathematics at the University of Southern California. He is an Alfred P. Sloan Fellow. He received his PhD degree in computer science from the State University of New York at Stony Brook in 1997. He was a lecturer of genetics and research fellow at Harvard University from 1997 to 2000. His research focuses on (1) the analysis of protein interactions, functions and pathways, (2) the protein identification and sequencing via HPLC-tandem mass spectrometry, and (3) the analysis of Human SNPs. Cho WC, Queen Elizabeth Hospital, Hong Kong Dr William Chi-shing Cho is a scientific officer at the Department of Clinical Oncology in Queen Elizabeth Hospital. He embarked his research work with biochemistry and Chinese medicine. After joining Queen Elizabeth Hospital, his main research interests have been focusing on local prevalent cancers such as nasopharyngeal carcinoma and lung cancer. Dr Cho’s recent work was featured at utilizing high-throughput mass spectrometry technology to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. Dr Cho is an editor on several scientific journals and has published more than 60 articles covering cancer biomarkers discovery, oncoproteomics, chronic diseases’ pharmacology and Chinese medicine in publications including Clin Chem, Clin Cancer Res, Ann Oncol, J Cell Biochem, Mol Cancer, etc. He has also published books and articles on the topics of cancer encyclopedia, cancer biomarkers and proteomics methodologies with Springer and Humana Press. Godovac Zimmermann J, University College London, United Kingdom Jasminka Godovac Zimmermann is Professor at University College London, UK and Head of the Molecular Dynamics Group. She is protein chemist trained at Max-Planck Institute for Biochemistry in Martinsried, Germany. Subsequently, she worked at the Australian National University in Canberra, Australia and the University of Mainz Institute for Molecular Biotechnology, Jena, Germany. She works on functional phosphoproteomics of signal transduction by membrane receptors. Her interest is shifting to cancer proteomics and the complexity of eukaryotic proteomics. She is an author of over 100 research papers and reviews and over 100 presentations. She is also a co- founder of two biotechnology companies. Grant S, Wellcome Trust Sanger Institute, Cambridge, UK Joos T, University of Tuebingen, Germany Dr Thomas Joos is head of the biochemistry department of the NMI Natural and Medical Sciences Institute at the University of Tuebingen. The NMI is a research foundation supported by the Ministry of Commerce of the Baden- Württemberg state. The Institute is associated with the University of Tuebingen. Scientists in the areas of applied and theoretical physics, chemistry, physical chemistry, biology and biochemistry are experienced in system analysis and problem solution for industrial clients. The R&D activities at the NMI are characterised by their multidisciplinary approach. Dr Joos has been with the NMI since 1998, where he has been responsible for protein microarray technology. Prior to joining the NMI, Dr Joos did his postdoctoral research in the laboratory of Prof. Peter Hausen at the Max-Planck-Institute of Developmental Biology, Department of Cell biology, researching cell-cell and cell-matrix interaction during early embryogenesis of Xenopus laevis. Dr Joos studied Biochemistry at the University of Tuebingen. He received his Ph.D. 5 during early embroygenesis of degree in 1985 on integrin- Xenopus laevis. Kondo T, National Cancer Center Research Institute, Japan Liotta LA, George Mason University, VA, USA Dr Lance A. Liotta, M.D., Ph.D. is Chief of the Laboratory of Pathology and Chief of the Section of Tumor Invasion and Metastases in the Division of Clinical Sciences, National Cancer Institute, NIH. He is the former Deputy Director for Intramural Research, NIH. He received his M.D./ Ph.D. at Case Western Reserve University in 1976. Dr Liotta's Ph.D. is in Biomedical Engineering. Dr Liotta served his residency training in anatomic pathology at the NIH in the Laboratory of Pathology. He became Chief of the same Laboratory in 1982. Dr Liotta was one of the first scientists to investigate the process of tumor invasion and metastasis at a molecular level. Dr Liotta and colleagues in the Laboratory of Pathology invented Laser Capture Microdissection (LCM) which is commercialized and used in more than 1000 labs worldwide. LCM has been applied to make broad discoveries in genomics, functional genetics, and is now extending into tissue proteomics. In partnership with Dr Emanuel Petricoin of the FDA, Dr Liotta initiated the first joint initiative between the FDA and the NCI to develop new technology for the discovery of proteins and the profiling of signal pathways in actual human tissue. He and Dr Petricoin were the first to use "Artificial Intelligence" type learning algorithms to discover disease-associated proteomic patterns in the serum of patients that correlates with the presence of early stage ovarian and prostate cancer (Petricoin et al Lancet 2002, 359:572-577). They were the first to propose and demonstrate that the low molecular weight blood proteome is a treasure trove of diagnostic and physiologic information. The information content is contained in 1000s of clipped and modified proteins and peptides shed from every tissue and cellular compartment. Mayer B, University of Connecticut Health Center, CT, USA Morozov V, George Mason University, USA Nakamura K, Yamaguchi University School of Medicine, Japan Kazuyuki Nakamura is Professor and Chairman of Department of Biochemistry and Biomolecular Recognition, Yamaguchi University School of Medicine, Japan. He served as Director of Central Laboratory for Biomedical Research and Education from 1992 to 2000, Director of University Library of Yamaguchi University from 2001 to 2003, and now he is Associate Dean of School of Medicine. He is serving for the promotion of proteomics as HUPO and AOHUPO Council Members and Co-Chair of Human Disease Glycomics Proteome Initiative (HGPI).
Load more

Recommended publications
  • Annual Scientific Report 2013 on the Cover Structure 3Fof in the Protein Data Bank, Determined by Laponogov, I
    EMBL-European Bioinformatics Institute Annual Scientific Report 2013 On the cover Structure 3fof in the Protein Data Bank, determined by Laponogov, I. et al. (2009) Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nature Structural & Molecular Biology 16, 667-669. © 2014 European Molecular Biology Laboratory This publication was produced by the External Relations team at the European Bioinformatics Institute (EMBL-EBI) A digital version of the brochure can be found at www.ebi.ac.uk/about/brochures For more information about EMBL-EBI please contact: [email protected] Contents Introduction & overview 3 Services 8 Genes, genomes and variation 8 Molecular atlas 12 Proteins and protein families 14 Molecular and cellular structures 18 Chemical biology 20 Molecular systems 22 Cross-domain tools and resources 24 Research 26 Support 32 ELIXIR 36 Facts and figures 38 Funding & resource allocation 38 Growth of core resources 40 Collaborations 42 Our staff in 2013 44 Scientific advisory committees 46 Major database collaborations 50 Publications 52 Organisation of EMBL-EBI leadership 61 2013 EMBL-EBI Annual Scientific Report 1 Foreword Welcome to EMBL-EBI’s 2013 Annual Scientific Report. Here we look back on our major achievements during the year, reflecting on the delivery of our world-class services, research, training, industry collaboration and European coordination of life-science data. The past year has been one full of exciting changes, both scientifically and organisationally. We unveiled a new website that helps users explore our resources more seamlessly, saw the publication of ground-breaking work in data storage and synthetic biology, joined the global alliance for global health, built important new relationships with our partners in industry and celebrated the launch of ELIXIR.
    [Show full text]
  • The HUPO Proteomics Standards Initiative Meeting: Towards Common Standards for Exchanging Proteomics Data Hinxton, Cambridge, UK, 19–20 October 2002
    Comparative and Functional Genomics Comp Funct Genom 2003; 4: 16–19. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/cfg.232 Feature Meeting Review: The HUPO Proteomics Standards Initiative meeting: towards common standards for exchanging proteomics data Hinxton, Cambridge, UK, 19–20 October 2002 Sandra Orchard, Paul Kersey, Henning Hermjakob* and Rolf Apweiler EMBL Outstation–European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK *Correspondence to: Abstract Henning Hermjakob, EMBL Outstation–European The Proteomics Standards Initiative (PSI) aims to define community standards Bioinformatics Institute, for data representation in proteomics and to facilitate data comparison, exchange Wellcome Trust Genome and verification. Initially the fields of protein–protein interactions (PPI) and mass Campus, Hinxton, Cambridge, spectroscopy have been targeted and the inaugural meeting of the PSI addressed the UK. questions of data storage and exchange in both of these areas. The PPI group rapidly E-mail: reached consensus as to the minimum requirements for a data exchange model; an [email protected] XML draft is now being produced. The mass spectroscopy group have achieved major advances in the definition of a required data model and working groups are currently taking these discussions further. A further meeting is planned in January 2003 to Received: 14 November 2002 advance both these projects. Copyright 2003 John Wiley & Sons, Ltd. Accepted: 14 November 2002 Keywords: proteomics; spectroscopy; protein–protein interactions Introduction process, before splitting into two working parties to address the issues facing their respective fields. The Proteomics Standards Initiative was estab- lished following a meeting in April 2002, jointly organized by HUPO and NAS, at which the urgent Protein–protein interactions (PPI) group need for standardization of proteomics data was recognized.
    [Show full text]
  • The European Bioinformatics Institute in 2020: Building a Global Infrastructure of Interconnected Data Resources for the Life Sciences Charles E
    Published online 8 November 2019 Nucleic Acids Research, 2020, Vol. 48, Database issue D17–D23 doi: 10.1093/nar/gkz1033 The European Bioinformatics Institute in 2020: building a global infrastructure of interconnected data resources for the life sciences Charles E. Cook *, Oana Stroe, Guy Cochrane ,EwanBirney and Rolf Apweiler European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK Received September 21, 2019; Revised October 18, 2019; Editorial Decision October 21, 2019; Accepted November 06, 2019 ABSTRACT ature. EMBL-EBI’s data resources collate, integrate, curate and make freely available to the public the world’s scientific Data resources at the European Bioinformatics In- data. stitute (EMBL-EBI, https://www.ebi.ac.uk/)archive, Our resources (www.ebi.ac.uk/services) include archival organize and provide added-value analysis of re- or deposition databases that store primary experimental search data produced around the world. This year’s data submitted by researchers, as well as knowledgebases update for EMBL-EBI focuses on data exchanges that integrate and add value to experimental data, with among resources, both within the institute and with many having both functions (1,2). All EMBL-EBI data re- a wider global infrastructure. Within EMBL-EBI, data sources, are open access and freely available to any user resources exchange data through a rich network of worldwide at any time, and EMBL-EBI strongly supports data flows mediated by automated systems. This net- the concept of FAIR data (findable, accessible, interopera- work ensures that users are served with as much ble, and resuable) (3).
    [Show full text]
  • 2003 Mulder Nucl Acids Res {22
    The InterPro Database, 2003 brings increased coverage and new features Nicola J Mulder, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Daniel Barrell, Alex Bateman, David Binns, Margaret Biswas, Paul Bradley, Peer Bork, et al. To cite this version: Nicola J Mulder, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Daniel Barrell, et al.. The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Research, Oxford University Press, 2003, 31 (1), pp.315-318. 10.1093/nar/gkg046. hal-01214149 HAL Id: hal-01214149 https://hal.archives-ouvertes.fr/hal-01214149 Submitted on 9 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. # 2003 Oxford University Press Nucleic Acids Research, 2003, Vol. 31, No. 1 315–318 DOI: 10.1093/nar/gkg046 The InterPro Database, 2003 brings increased coverage and new features Nicola J. Mulder1,*, Rolf Apweiler1, Teresa K. Attwood3, Amos Bairoch4, Daniel Barrell1, Alex Bateman2, David Binns1, Margaret Biswas5, Paul Bradley1,3, Peer Bork6, Phillip Bucher7, Richard R. Copley8, Emmanuel Courcelle9, Ujjwal Das1, Richard Durbin2, Laurent Falquet7, Wolfgang Fleischmann1, Sam Griffiths-Jones2, Downloaded from Daniel Haft10, Nicola Harte1, Nicolas Hulo4, Daniel Kahn9, Alexander Kanapin1, Maria Krestyaninova1, Rodrigo Lopez1, Ivica Letunic6, David Lonsdale1, Ville Silventoinen1, Sandra E.
    [Show full text]
  • MPGM: Scalable and Accurate Multiple Network Alignment
    MPGM: Scalable and Accurate Multiple Network Alignment Ehsan Kazemi1 and Matthias Grossglauser2 1Yale Institute for Network Science, Yale University 2School of Computer and Communication Sciences, EPFL Abstract Protein-protein interaction (PPI) network alignment is a canonical operation to transfer biological knowledge among species. The alignment of PPI-networks has many applica- tions, such as the prediction of protein function, detection of conserved network motifs, and the reconstruction of species’ phylogenetic relationships. A good multiple-network align- ment (MNA), by considering the data related to several species, provides a deep understand- ing of biological networks and system-level cellular processes. With the massive amounts of available PPI data and the increasing number of known PPI networks, the problem of MNA is gaining more attention in the systems-biology studies. In this paper, we introduce a new scalable and accurate algorithm, called MPGM, for aligning multiple networks. The MPGM algorithm has two main steps: (i) SEEDGENERA- TION and (ii) MULTIPLEPERCOLATION. In the first step, to generate an initial set of seed tuples, the SEEDGENERATION algorithm uses only protein sequence similarities. In the second step, to align remaining unmatched nodes, the MULTIPLEPERCOLATION algorithm uses network structures and the seed tuples generated from the first step. We show that, with respect to different evaluation criteria, MPGM outperforms the other state-of-the-art algo- rithms. In addition, we guarantee the performance of MPGM under certain classes of net- work models. We introduce a sampling-based stochastic model for generating k correlated networks. We prove that for this model if a sufficient number of seed tuples are available, the MULTIPLEPERCOLATION algorithm correctly aligns almost all the nodes.
    [Show full text]
  • EMBL-EBI-Overview.Pdf
    EMBL-EBI Overview EMBL-EBI Overview Welcome Welcome to the European Bioinformatics Institute (EMBL-EBI), a global hub for big data in biology. We promote scientific progress by providing freely available data to the life-science research community, and by conducting exceptional research in computational biology. At EMBL-EBI, we manage public life-science data on a very large scale, offering a rich resource of carefully curated information. We make our data, tools and infrastructure openly available to an increasingly data-driven scientific community, adjusting to the changing needs of our users, researchers, trainees and industry partners. This proactive approach allows us to deliver relevant, up-to-date data and tools to the millions of scientists who depend on our services. We are a founding member of ELIXIR, the European infrastructure for biological information, and are central to global efforts to exchange information, set standards, develop new methods and curate complex information. Our core databases are produced in collaboration with other world leaders including the National Center for Biotechnology Information in the US, the National Institute of Genetics in Japan, SIB Swiss Institute of Bioinformatics and the Wellcome Trust Sanger Institute in the UK. We are also a world leader in computational biology research, and are well integrated with experimental and computational groups on all EMBL sites. Our research programme is highly collaborative and interdisciplinary, regularly producing high-impact works on sequence and structural alignment, genome analysis, basic biological breakthroughs, algorithms and methods of widespread importance. EMBL-EBI is an international treaty organisation, and we serve the global scientific community.
    [Show full text]
  • Annual Scientific Report 2011 Annual Scientific Report 2011 Designed and Produced by Pickeringhutchins Ltd
    European Bioinformatics Institute EMBL-EBI Annual Scientific Report 2011 Annual Scientific Report 2011 Designed and Produced by PickeringHutchins Ltd www.pickeringhutchins.com EMBL member states: Austria, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom. Associate member state: Australia EMBL-EBI is a part of the European Molecular Biology Laboratory (EMBL) EMBL-EBI EMBL-EBI EMBL-EBI EMBL-European Bioinformatics Institute Wellcome Trust Genome Campus, Hinxton Cambridge CB10 1SD United Kingdom Tel. +44 (0)1223 494 444, Fax +44 (0)1223 494 468 www.ebi.ac.uk EMBL Heidelberg Meyerhofstraße 1 69117 Heidelberg Germany Tel. +49 (0)6221 3870, Fax +49 (0)6221 387 8306 www.embl.org [email protected] EMBL Grenoble 6, rue Jules Horowitz, BP181 38042 Grenoble, Cedex 9 France Tel. +33 (0)476 20 7269, Fax +33 (0)476 20 2199 EMBL Hamburg c/o DESY Notkestraße 85 22603 Hamburg Germany Tel. +49 (0)4089 902 110, Fax +49 (0)4089 902 149 EMBL Monterotondo Adriano Buzzati-Traverso Campus Via Ramarini, 32 00015 Monterotondo (Rome) Italy Tel. +39 (0)6900 91402, Fax +39 (0)6900 91406 © 2012 EMBL-European Bioinformatics Institute All texts written by EBI-EMBL Group and Team Leaders. This publication was produced by the EBI’s Outreach and Training Programme. Contents Introduction Foreword 2 Major Achievements 2011 4 Services Rolf Apweiler and Ewan Birney: Protein and nucleotide data 10 Guy Cochrane: The European Nucleotide Archive 14 Paul Flicek:
    [Show full text]
  • Multi-Platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes
    bioRxiv preprint doi: https://doi.org/10.1101/193144; this version posted June 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Multi-platform discovery of haplotype-resolved structural variation in human genomes Mark J.P. Chaisson1,2*, Ashley D. Sanders3*, Xuefang Zhao4,5*, Ankit Malhotra6†, David Porubsky7,8†, Tobias Rausch3†, Eugene J. Gardner9†, Oscar Rodriguez10†, Li Guo11†, Ryan L. Collins5†, Xian Fan14†, Jia Wen15†, Robert E. Handsaker16,42†, Susan Fairley17†, Zev N. Kronenberg1†, Xiangmeng Kong18†, Fereydoun Hormozdiari19,20†, Dillon Lee21†, Aaron M. Wenger22†, Alex Hastie23†, Danny Antaki24†, Peter Audano1, Harrison Brand5, Stuart Cantsilieris1, Han Cao25, Eliza Cerveira6, Chong Chen14, Xintong Chen9, Chen-Shan Chin22, Zechen Chong14, Nelson T. Chuang9, Christine C. Lambert22, Deanna M. Church26, Laura Clarke17, Andrew Farrell21, Joey Flores27, Timur Galeev18, David Gorkin35,36, Madhusudan Gujral24, Victor Guryev7, William Haynes Heaton26, Jonas Korlach22, Sushant Kumar18, Jee Young Kwon6,46, Jong Eun Lee28, Joyce Lee23, Wan-Ping Lee6, Sau Peng Lee31, Shantao Li13, Patrick Marks26, Karine Viaud-Martinez27, Sascha Meiers3, Katherine M. Munson1, Fabio Navarro18, Bradley J. Nelson1, Conor Nodzak15, Amina Noor24, Sofia Kyriazopoulou- Panagiotopoulou26, Andy Pang23, Yunjiang Qiu25,28, Gabriel Rosanio24, Mallory Ryan6, Adrian Stütz3, Diana C.J. Spierings7, Alistair Ward21, AnneMarie E. Welch1, Ming Xiao32, Wei Xu26, Chengsheng Zhang6, Qihui Zhu6, Xiangqun Zheng-Bradley17, Ernesto Lowy17, Sergei Yakneen3, Steven McCarroll16,42⊗, Goo Jun33⊗, Li Ding34⊗, Chong Lek Koh30⊗, Bing Ren35,36⊗, Paul Flicek17§⊗, Ken Chen14§⊗, Mark B.
    [Show full text]
  • UC Riverside UC Riverside Previously Published Works
    UC Riverside UC Riverside Previously Published Works Title Structural genomics is the largest contributor of novel structural leverage. Permalink https://escholarship.org/uc/item/82z2z1fg Journal Journal of structural and functional genomics, 10(2) ISSN 1345-711X Authors Nair, Rajesh Liu, Jinfeng Soong, Ta-Tsen et al. Publication Date 2009-04-01 DOI 10.1007/s10969-008-9055-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California J Struct Funct Genomics (2009) 10:181–191 DOI 10.1007/s10969-008-9055-6 Structural genomics is the largest contributor of novel structural leverage Rajesh Nair Æ Jinfeng Liu Æ Ta-Tsen Soong Æ Thomas B. Acton Æ John K. Everett Æ Andrei Kouranov Æ Andras Fiser Æ Adam Godzik Æ Lukasz Jaroszewski Æ Christine Orengo Æ Gaetano T. Montelione Æ Burkhard Rost Received: 15 November 2008 / Accepted: 8 December 2008 / Published online: 5 February 2009 Ó The Author(s) 2009. This article is published with open access at Springerlink.com Abstract The Protein Structural Initiative (PSI) at the US structures for protein sequences with no structural repre- National Institutes of Health (NIH) is funding four large- sentative in the PDB on the date of deposition). The scale centers for structural genomics (SG). These centers structural coverage of the protein universe represented by systematically target many large families without structural today’s UniProt (v12.8) has increased linearly from 1992 to coverage, as well as very large families with inadequate 2008; structural genomics has contributed significantly to structural coverage. Here, we report a few simple metrics the maintenance of this growth rate.
    [Show full text]
  • Interpro: the Integrative Protein Signature Database
    InterPro: the integrative protein signature database Sarah Hunter, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Alex Bateman, David Binns, Peer Bork, Ujjwal Das, Louise Daugherty, Lauranne Duquenne, et al. To cite this version: Sarah Hunter, Rolf Apweiler, Teresa K Attwood, Amos Bairoch, Alex Bateman, et al.. InterPro: the integrative protein signature database. Nucleic Acids Research, Oxford University Press, 2009, 37 (Database issue), pp.D211-D215. 10.1093/nar/gkn785. hal-01214141 HAL Id: hal-01214141 https://hal.archives-ouvertes.fr/hal-01214141 Submitted on 9 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Published online 21 October 2008 Nucleic Acids Research, 2009, Vol. 37, Database issue D211–D215 doi:10.1093/nar/gkn785 InterPro: the integrative protein signature database Sarah Hunter1,*, Rolf Apweiler1, Teresa K. Attwood2, Amos Bairoch3, Alex Bateman4, David Binns1, Peer Bork5, Ujjwal Das1, Louise Daugherty1, Lauranne Duquenne6, Robert D. Finn4, Julian Gough7, Daniel Haft8, Nicolas Hulo3, Daniel Kahn6, Elizabeth Kelly9, Aure´ lie Laugraud6, Ivica Letunic5, David Lonsdale1, Rodrigo Lopez1, Martin Madera7, John Maslen1, Craig McAnulla1, Jennifer McDowall1, Jaina Mistry4, Downloaded from Alex Mitchell1,2, Nicola Mulder9, Darren Natale10, Christine Orengo11, Antony F.
    [Show full text]
  • Speaker Biographies
    Speaker Biographies Dr Rolf Apweiler is Director of EMBL-EBI, together with Ewan Birney. He also is the current Director of Open Targets. Prior to this position he was Joint Associate Director, after many years of leading protein resources such as UniProt. Rolf has made major contributions to methods for the automatic annotation of proteins, making it possible to add relevant information to whole proteome sets. Rolf received his PhD from the University of Heidelberg in 1994, and has been at EMBL since 1987. Dr Haruki Nakamura is Professor Emeritus and Former Director of Institute for Protein Research, Osaka University. He founded the Protein Data Bank Japan (PDBj) in 2001 and worked as the PI, collaborating with the other wwPDB partners including PDBe-EBI. He now works at National Institute of Genetics, Mishima, as a Specially Appointed Professor. He is also engaged in promotion of the Japanese project for supporting innovative drug discovery and life science research (AMED-BINDS) as the program supervisor. Dr Kazuhisa Tsunoyama is the director of Analytics and Informatics group, Real World Informatics and Analytics function at Astellas Pharma Inc. He has ben working on bioinformatics research and medical big data analysis since joining the company. In 2010, he led participation in the EBI Industry Programme. He was a visiting researcher at Imperial College London, UK from 2006 to 2008 and he was seconded to Astellas US LLC from 2016 to 2017. Dr Dominic Clark is the Industry Programme Manager at EMBL- EBI. The Industry Programme is a subscription-based programme for global companies that make significant use of the data and resources provided by EMBL-EBI.
    [Show full text]
  • Planning for Globally Sustainable Life Sciences Data Resources
    PLANNING FOR GLOBALLY SUSTAINABLE LIFE SCIENCES DATA RESOURCES W. Anderson1, R. Appel8, R. Apweiler2, G.A. Bauer1, H. Berman3, N. Blomberg4, C.H. de Brito Cruz5, T. Donohue6, M. Dunn7, C. Durinx8, P. Goodhand9, E.D. Green10, J. McEntyre2, Y. Nakamura11, A. Smith2, Y-Y. Teo12, M. Woodwark13, and P. Lasko14 1: The International Human Frontier Science Program Organization, 12 Quai Saint-Jean, 67080 Strasbourg, France 2: European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK 3: Rutgers University, Center for Integrative Proteomics Research (CIPR), SAS - Chemistry & Chemical Biology, 174 Frelinghuysen Rd, Piscataway, NJ 08854-8076, USA 4: ELIXIR, Wellcome Genome Campus, Hinxton, CB10 1SD, UK 5: The Sao Paulo Research Foundation, R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 Sao Paulo/SP, Brazil 6: Department of Bacteriology, Great Lakes Bioenergy Research Center, & Wisconsin Energy Institute, University of Wisconsin-Madison, 1552 University Avenue, Madison, WI 53726, USA 7: The Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK Wisconsin-Madison, 1552 University Avenue, Madison, WI 53726, USA 8: SIB Swiss Institute of Bioinformatics, University of Lausanne, Batiment Genopode, 1015 Lausanne, Switzerland 9: Global Alliance for Genomics and Health, MaRS Centre, 661 University Avenue, Suite 510, Toronto, Ontario, Canada, M5G 0A3 10: National Human Genome Research Institute, National Institutes of Health, 31 Center Dr., Bethesda, MD 20892, USA 11: National Institute
    [Show full text]